|
Online edition of India's National Newspaper Thursday, July 26, 2001 |
|
Front Page |
National |
Southern States |
Other States |
International |
Opinion |
Business |
Sport |
Science & Tech |
Entertainment |
Miscellaneous |
Features |
Classifieds |
Employment |
Index |
Home |
|
Science & Tech
| Previous
| Next
Drug resistant bacteria, killer at large
When first discovered, antibiotics were touted as a miracle cure
and they literally were. Infections that were fatal were tamed to
mere inconveniences. The misuse, overprescription and abuse of
antibiotics has allowed resistant strains of bacteria to develop
and once again threaten health and life. HORROR MOVIES
graphically reveal the ravages of killer plagues and flesh eating
bacteria but behind this filmi-hype is a story of real and
imminent danger. Recently the deadly bacterium Staphylococcus
aureus, a major cause of hospital acquired infections, was found
to respond poorly to a once reliable antidote {frac12}the
antibiotic vancomycin. This emergence of forms of the bacteria,
lacking sensitivity to vancomycin signifies that variants
untreatable by every known antibiotic are on their way and this
bacterium has thus moved one step closer to becoming an
unstoppable killer. In addition, strains of at least three
bacteria capable of causing life-threatening illness,
Enterococcus faecalis, Mycobacterium tuberculosis and Pseudomonas
aeruginosa already evade every antibiotic in the clinicians
armamentarium, a stockpile of more than 100 drugs. The looming
threat of such incurable bacterial species is just the latest
twist in an international public health nightmare increased
bacterial resistance to many antibiotics that once cured
bacterial diseases readily.
The World Health Organization(WHO) in fact in a very recently
released report on " Overcoming Antimicrobial Resistance " has
issued an urgent call for action on the fight against increasing
microbial resistance to therapeutic drugs.
"If nothing is done in this decade to tackle the problem, the
window of opportunity may be closed forever," says WHO in its
report. The effect of antimicrobial resistance , the report
emphasizes, "is that it can reduce the curative power of once
life-saving medicines to that of a sugar pill".
When first discovered, antibiotics were touted as a miracle cure
and they literally were. Infections that were fatal were tamed to
mere inconveniences. The misuse, over prescription and abuse of
antibiotics has allowed resistant strains of bacteria to develop
and once again threaten health and life. With each passing
decade, bacteria that defy not only single but multiple
antibiotics and therefore are extremely difficult to control have
become increasingly common.
The WHO report points out that there are two reasons for the
increasing resistance to antimicrobial therapies: in the
developed world it is overuse of drugs and in the developing
world it is their underuse. As a result, diseases that were
virtually eliminated with the introduction of antibiotics are
mutating, gaining strength and resisting treatment. About 10% of
TB patients have strains resistant to the two most powerful TB
medicines. A small but growing number of HIV patients is becoming
resistant to AZT treatment. Penicillin has become virtually
useless for treating gonnorrhoea and even in industrialized
countries, up to 60% of hospital-acquired infections are caused
by drug-resistant microbes. The economic impact of drug
resistance is enormous. It costs 100 times more to treat a
patient with drug resistant TB than one with normal TB.
In an effort to combat the menace of drug resistant bacteria, it
is important to realize that although antibiotics are needed to
control bacterial infections, they can have broad, undesirable
effects on microbial ecology.
That is, they can produce long - lasting change in the kinds and
proportions of bacteria - and the mix of antibiotic-resistant and
antibiotic-susceptible types- not only in the treated individual
but also in the environment and society at large. Antibiotics
should thus be used only when they are truly needed and we can
all help in reversing the growth of resistant bacteria by doing
the following:
Complete the full course of antibiotic therapy to ensure that all
the pathogen bacteria are killed. Also do not skip doses since
this causes the level of antibiotic in the blood to drop
providing bacteria with a `breather'. As a result, some may
survive.
Refrain from taking antibiotics for colds and other viral
infections because antibiotics DO NOT harm viruses. One should
also consider seeking non-antibiotic therapies for minor
ailments.
It is believed that approximately one third to one half of all
antibiotic prescriptions are not needed.
Wash raw fruits and vegetables to thoroughly clear off any
resistant bacteria. The amount of resistant bacteria people
acquire from food is not trivial. It has been shown in a study
conducted by the National Institute for Agricultural Research in
Toulouse, France that when human volunteers went on a diet
consisting only of bacteria free foods, the number of resistant
bacteria in their feces decreased 1000 fold.
The ultimate weapon for outwitting the resistant bacteria would
of course be to develop altogether new types of antibiotics. And
there is very definite hope in this direction. Only in April 1999
the United States Food and Drug Administration (USFDA) approved
the drug `Zyvox' for use by adults with pneumonia and other
infections caused by the deadly supergerm enterococcus faecium
which is resistant to all antibiotics including vancomycin. More
importantly, Zyvox is a synthetic chemical designed from scratch
to fight germs at an entirely different point in their life cycle
than any other antibiotic.
In contrast to present day antibiotics, Zyvox stops bacteria from
multiplying by halting production of proteins vital to their
growth early in their life cycle.
It is believed that because Zyvox works differently than
traditional antibiotics, it would probably be harder for bacteria
to evolve resistance to it. There is also new hope from the
findings of the Human Genome Project. Analysis of bacterial
genomic sequences has shown that there could be 20-200 novel
targets on the bacteria for attack by antibiotics.
The existing seven classes of antibiotics are known to attack
only a handful of these bacterial sites. There is scope therefore
for the development of newer class of antibiotics that will kill
bacteria by binding to these newly discovered bacterial targets.
Scientists are also working on strategies that will give new life
to existing antibiotics. Many bacteria for instance evade
penicillin and its relatives by switching on an enzyme,
penicillinase that degrades those compounds. An antidote already
on pharmacy shelves contains an inhibitor of penicillinase.
It prevents the breakdown of penicillin by the bacteria and so
frees the antibiotic to work normally. Similarly scientists are
working towards developing a compound to jam a microbial pump
that ejects the drug tetracycline from bacteria. With the pump
inactivated tetracycline can penetrate bacterial cells
effectively.
Anirudha Datta
Indian Institute Of Petroleum
Dehradun
Send this article to Friends by E-Mail
|
|
Section : Science & Tech Previous : Oral protection against sexual transmission Next : Brain stores perceptions into small meaningful chunks | |
|
Front Page |
National |
Southern States |
Other States |
International |
Opinion |
Business |
Sport |
Science & Tech |
Entertainment |
Miscellaneous |
Features |
Classifieds |
Employment |
Index |
Home | |
|
Copyrights © 2001 The Hindu Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu |
|